Natalie Serkova

Professor and Vice Chair Research

University of Colorado Anschutz Medical Campus

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Natalie Serkova is a Professor and Vice Chair of Research at the University of Colorado Anschutz Medical Campus. Her research focuses on pediatric brain tumors, blood-brain barrier dynamics, and nanomedicine, as highlighted by her recent articles on therapeutic strategies for medulloblastoma and gliomas. Dr. Serkova's work addresses the complexities of cancer treatment and innovative approaches to enhance patient outcomes.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (4)

Warren C. W. Chan

University of Toronto

CANADA

View details

Todd Pitts

UNITED STATES

View details

Agata Exner

Henry Willson Payne Professor

Case Western Reserve University

UNITED STATES

View details

Ninh La-Beck

Texas Tech University Health Sciences Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Natalie Serkova

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRT.

Targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions

A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors

Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma

Comprehensive assessment of blood-brain barrier opening and sterile inflammatory response: unraveling the therapeutic window.

Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy.

Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.

Immunocal® limits gliosis in mouse models of repetitive mild-moderate traumatic brain injury

Collaborators (4)

Warren C. W. Chan

Todd Pitts

Agata Exner

Ninh La-Beck

Make your next move.